Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06320067 |
| Title | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer (STAMPEDE2) |
| Acronym | STAMPEDE2 |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | University College, London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |